comfirmed that lapatinib-induced FoxO transcription factors upregulated c-Myc epigenetically in cooperation with a cascade of epigenetic regulators associated with MLL2 to inhibit sensitivity of the breast cancer cells to lapatinib [25]. This evidence concerns the gene MYC and breast carcinoma.